WINDSOR, Conn., April 11, 2017 -- The Vascular Experts, a nationally recognized vascular surgery medical group, has selected Meridian Medical Management to provide revenue cycle management and healthcare technology services. The Vascular Experts will utilize Meridian’s proprietary robotic process automation suite, the VertexDr practice management and electronic medical record application, and the PrecisionBI analytics engine.
“We have selected Meridian as our partner so we can focus on delivery of care to our patients. The Vascular Experts are in the process of expanding and are enabling patients from around the United States to experience high quality healthcare that patients from the New England area have experienced for over 16 years,” said Andrew Castaldi, COO.
With more than 20 years of experience, Meridian Medical Management supports independent medical groups and leading academic medical centers, helping them realize new revenue sources through their proprietary revenue cycle management process. The company promotes quality and revenue growth initiatives through delivering technology, analytics, lean processes, and revenue cycle services to its customers.
“Meridian Medical Management has experienced dynamic growth in all of its divisions. Our focus is to partner with our clients and enable them to focus on their mission. Our expansion is driven by our commitment to our customers,” according to Karen Simonenko, EVP Multi-Specialty Operations.
About The Vascular Experts
Founded in 2001 to deliver expert vascular medical and surgical care to the communities of Southern Connecticut and New York, The Vascular Experts is now one of the largest groups of board-certified vascular surgeons in the country. All of our surgeons are Board Certified and have been trained in the latest endovascular procedures at well-known accredited academic centers. For more information, please visit www.thevascularexperts.com.
About Meridian Medical Management
Meridian Medical Management, a portfolio company of The Gores Group, is a leading provider of revenue cycle, business intelligence, EMR and system integration services for large, multi-specialty physician groups and academic practice plans. Leveraging over two decades of experience, Meridian’s team of professionals provides revenue cycle performance, business intelligence and practice growth to some of the most prestigious medical groups in the country. For more information, please visit www.m3meridian.com.
For more Information regarding Meridian Medical Management and the Revenue Acceleration Program and other Meridian companies inclusive of PrecisionBI and Origin Healthcare Solutions, follow us on LinkedIn and Twitter.
About The Gores Group
The Gores Group, founded in 1987 by Alec Gores, is a global investment firm focused on acquiring controlling interests in mature and growing businesses which can benefit from the firm’s operating experience and flexible capital base. The firm combines the operational expertise and detailed due diligence capabilities of a strategic buyer with the seasoned M&A team of a traditional financial buyer. Over its 30 year history, The Gores Group has become a leading investor, having demonstrated a reliable track record of creating value in its portfolio companies alongside management. Headquartered in Los Angeles, The Gores Group maintains offices in Boulder, Co., and London. For more information, please visit http://www.gores.com.
Media Contact: Bill Stone EVP Sales & Marketing [email protected]


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



